000150349 001__ 150349
000150349 005__ 20210129213144.0
000150349 0247_ $$2doi$$a10.1016/j.expneurol.2014.01.005
000150349 0247_ $$2wos$$aWOS:000333321300008
000150349 0247_ $$2altmetric$$aaltmetric:2058412
000150349 0247_ $$2pmid$$apmid:24444545
000150349 037__ $$aFZJ-2014-00419
000150349 082__ $$a610
000150349 1001_ $$0P:(DE-HGF)0$$aBoller, J. K.$$b0
000150349 245__ $$aDecision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
000150349 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2014
000150349 3367_ $$2DRIVER$$aarticle
000150349 3367_ $$2DataCite$$aOutput Types/Journal article
000150349 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1504179570_31194
000150349 3367_ $$2BibTeX$$aARTICLE
000150349 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000150349 3367_ $$00$$2EndNote$$aJournal Article
000150349 520__ $$aInconsistent findings regarding the effects of dopaminergic medication (MED) and deep brain stimulation (DBS) of the subthalamic nucleus (STN) on decision making processes and impulsivity in Parkinson's disease (PD) patients have been reported. This study investigated the influence of MED and STN-DBS on decision-making under risk. Eighteen non-demented PD patients, treated with both MED and STN-DBS (64.3 ± 10.2 years, UPDRS III MED off, DBS off 45.5 ± 17.1) were tested with the Game of Dice Task (GDT) which probes decision-making under risk during four conditions: MED on/DBS on, MED on/DBS off, MED off/DBS on, and MED off/DBS off. Task performance across conditions was compared analyzing two GDT-parameters: (i) the “net score” indicating advantageous decisions, and (ii) the patient's ability to use negative feedback. Significantly higher GDT net scores were observed in Med on in contrast to Med off conditions as well as in DBS on versus DBS off conditions. However, no effect of therapy for the patient's ability to make use of negative feedback could be detected. The data suggest a positive influence of both MED and STN-DBS on making decisions under risk in PD patients, an effect which seems to be mediated by mechanisms other than the use of negative feedback
000150349 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000150349 536__ $$0G:(DE-HGF)POF2-89572$$a89572 - (Dys-)function and Plasticity (POF2-89572)$$cPOF2-89572$$fPOF II T$$x1
000150349 7001_ $$0P:(DE-Juel1)131613$$aBarbe, Michael$$b1
000150349 7001_ $$0P:(DE-HGF)0$$aPauls, A. M.$$b2
000150349 7001_ $$0P:(DE-HGF)0$$aReck, C.$$b3
000150349 7001_ $$0P:(DE-HGF)0$$aBrand, M.$$b4
000150349 7001_ $$0P:(DE-HGF)0$$aMaier, F.$$b5
000150349 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b6
000150349 7001_ $$0P:(DE-HGF)0$$aTimmermann, L.$$b7
000150349 7001_ $$0P:(DE-HGF)0$$aKalbe, E.$$b8$$eCorresponding author
000150349 773__ $$0PERI:(DE-600)1466932-8$$a10.1016/j.expneurol.2014.01.005$$p70–77$$tExperimental neurology$$v254$$x1090-2430$$y2014
000150349 8564_ $$uhttps://juser.fz-juelich.de/record/150349/files/FZJ-2014-00419.pdf$$yRestricted$$zPublished final document.
000150349 909CO $$ooai:juser.fz-juelich.de:150349$$pVDB
000150349 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131613$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000150349 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich GmbH$$b6$$kFZJ
000150349 9132_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000150349 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000150349 9131_ $$0G:(DE-HGF)POF2-89572$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$v(Dys-)function and Plasticity$$x1
000150349 9141_ $$y2014
000150349 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000150349 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000150349 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000150349 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000150349 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000150349 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000150349 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000150349 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000150349 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000150349 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000150349 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000150349 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000150349 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000150349 980__ $$ajournal
000150349 980__ $$aVDB
000150349 980__ $$aI:(DE-Juel1)INM-3-20090406
000150349 980__ $$aUNRESTRICTED